AlphaFold predicted structure
NRDC · O43847

Mean pLDDT
82.6/ 100
Confident
1,151 residues
Confidence breakdown
- Very high(≥ 90)69%
- Confident(70–90)14%
- Low(50–70)1%
- Very low(< 50)16%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
nardilysin convertase
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Arthrogryposis
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalOptic neuropathy
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalmajor depressive disorder
obesity disorder
attention deficit-hyperactivity disorder
major depressive episode
neurodevelopmental disorder
placental abruption
microcephaly
optic nerve disorder
Optic neuropathy
complex neurodevelopmental disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Nardilysin
Cleaves peptide substrates on the N-terminus of arginine residues in dibasic pairs. Is a critical activator of BACE1- and ADAM17-mediated pro-neuregulin ectodomain shedding, involved in the positive regulation of axonal maturation and myelination. Required for proper functioning of 2-oxoglutarate dehydrogenase (OGDH) (By similarity)
NRDC · O43847

Mean pLDDT
82.6/ 100
Confident
1,151 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0